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934Objective: We have performed an original aortic valve reconstruction using autologous pericardium. The
feasibility for patients aged less than 60 years is reviewed.
Methods: From April 2007 to April 2013, aortic valve reconstruction was performed in 108 patients aged
less than 60 years. A total of 51 patients had aortic stenosis, 7 patients had annuloaortic ectasia, 7 patients
had infective endocarditis, and 43 patients had aortic regurgitation. Fifty-seven patients had bicuspid
valves, and 11 patients had unicuspid valves. There were 75 male and 33 female patients, with a mean
age of 47.8  11.2 years. Preoperative echocardiography showed an average peak pressure gradient of
86.1  35.1 mm Hg with aortic stenosis. The surgical procedure is based on the independent tricuspid
replacement using autologous pericardium. First, the distance between the commissures is measured using an
original sizing apparatus, and then the pericardial cusp is trimmed using an original template and sutured to
the annulus.
Results: There was no conversion to prosthetic valve replacement. There were no in-hospital mortalities.
Postoperative echocardiography showed an average peak pressure gradient of 14.8  7.8 mm Hg 1 week after
surgery and 12.8  3.1 mm Hg 4 years after surgery. One patient required reoperation because of infective
endocarditis. The other 107 patients showed less than mild aortic regurgitation. No thromboembolic events
were recorded. The mean follow-up period was 34.2  15.7 months. Freedom from reoperation was 98.9%
with 76 months of follow-up.
Conclusions: Original aortic valve reconstruction was feasible for patients aged less than 60 years. Long-term
data will be disclosed in the future. (J Thorac Cardiovasc Surg 2014;148:934-8)Aortic valve reconstruction is the gold standard of surgical
treatment for various aortic valve diseases, especially for
adults. Bioprosthetic valves are used increasingly because
of the complications with inevitable postoperative anticoagu-
lation of mechanical valves.1,2 However, despite the progress
of the design and construction of prosthetic valves,
hemodynamic performance is not yet comparable to that of
native aortic valves. Moreover, replacement with a
bioprosthesis can cause accelerated degeneration in young
patients because of fibrosis and calcification.3 Immune
reaction may play a role in the degeneration of the implanted
bioprosthesis, especially in younger patients.4,5
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The Journal of Thoracic and Cardiovascular Surgfor aortic valve disease, but they have been performed
in only a select group of patients by a limited group of
well-experienced surgeons or interventionists.
Our original aortic valve reconstruction has been per-
formed since April 2007. The initial report of 88 patients
undergoing this operation was published in 2011.6 This is
a unique operation that consists of independent replacement
of 3 aortic valve cusps by glutaraldehyde-treated autolo-
gous pericardium and that preserves the natural motion of
the aortic annulus during the cardiac cycle. In the current
study, we inspected the feasibility of our original aortic
valve reconstruction for patients aged less than 60 years.
METHODS
Our original aortic valve reconstruction and the clinical study of this
operation were approved by the institutional review board of Toho
University Ohashi Medical Center. All patients underwent this operation
after written, informed consent had been obtained.
Our original aortic valve reconstruction was performed between
April 2007 and April 2013 in 108 patients aged less than 60 years.
We retrospectively reviewed our clinical data of all 108 patients and
evaluated their short- and midterm results.
There were 75 male and 33 female patients, with a mean age of
47.8  11.2 years. The age distribution of all 108 patients of the current
study group is shown in Figure 1. A total of 51 patients had aortic stenosis
(AS), 43 patients had aortic regurgitation, 7 patients had annuloaortic
ectasia, and 7 patients had infective endocarditis. A total of 57
patients had bicuspid aortic valves, and 11 patients had unicuspid valves.ery c September 2014
Abbreviation and Acronym
AS ¼ aortic stenosis
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DPreoperative echocardiography showed that the peak pressure gradient
through the aortic valve averaged 86.1  35.1 mm Hg in 51 patients
with AS.
Surgical Technique
The surgical technique of our original aortic valve reconstruction has
been reported.6,7 Preparation of the autologous pericardium began with
cleansing fat and other redundant tissue on the outer surface of the
pericardium using the Harmonic scalpel (Ethicon Endo-Surgery, Inc,
Cincinnati, Ohio). The pericardium was excised to approximately
7 3 8 cm and treated with 0.6% glutaraldehyde solution with buffer for
10 minutes. The treated pericardium was rinsed 3 times using a sterilized
physiologic saline solution, with a duration of 6 minutes per rinse. All of
the aortic valve reconstructive procedures were performed during
cardioplegic arrest on cardiopulmonary bypass.
First in the procedure, the diseased cusps are excised meticulously.
In the case of thick calcification along the aortic annulus, the Cavitron
Ultrasonic Surgical Aspirator (SonoSurg, Olympus, Tokyo, Japan) is
helpful in removing it without damaging annular tissue. The distance
between each commissure is measured using our original sizing apparatus.
From the glutaraldehyde-treated autologous pericardium, the new cusp
with the size corresponding to the measured value is trimmed using our
original template. Last, the annularmargin of the pericardial cusp is sutured
with running 4-0 monofilament stitches to each annulus. The running su-
ture should be performed to make a nice gather, creating a 3-dimensional
natural bulge of the cusps. Each pericardial cusp is sewn all the way to
the top of the commissure. The reason behind this design is to have a longer
coaptation zone, up to the same horizontal plane as the commissures.
Commissural coaptation is secured with additional 4-0 monofilament
sutures. The coaptation of the 3 new cusps is always ensured with direct
vision under negative pressure made by a left ventricular vent before aor-
totomy closure. In patients with aortic regurgitation or bicuspid/unicuspid
valves, we encircle the aorta at the commissural level with a 5-mm–wide
felt strip after de-clamping the aorta to prevent the future dilatation of
the aorta and eventual recurrence of regurgitation (Figure 2).
Follow-up
All patients were followed up at the outpatient clinic of Toho University
Ohashi Medical Center or at the referral hospital. Echocardiographic
evaluation was performed 1 week, 1 month, 3 months, and every 6 months
after surgeries.
Statistical Analysis
Data are presented as mean standard deviation. Survival and freedom
from reoperation rate were calculated by the Kaplan–Meier method.FIGURE 1. Age distribution of all 108 patients in the current study.RESULTS
There were no conversions to prosthetic valve replace-
ment. There were no in-hospital mortalities recorded.
Postoperative echocardiography showed an average peak
pressure gradient of 14.8 7.8 mmHg 1 week after surgery
and 12.8  3.1 mm Hg 4 years after surgery. No cusp
calcification was recorded during the entire follow-up
period. One patient required reoperation because of infec-
tive endocarditis. The other 107 patients showed less thanThe Journal of Thoracic and Camild aortic regurgitation. No thromboembolic events were
recorded even without anticoagulation. The mean follow-
up period was 34.2  15.7 months. Survival and freedom
from reoperation were 96.9% and 98.9%, respectively, at
76 months follow-up (Figure 3).
Because our technique is tricuspid reconstruction for all
patients, including those with bicuspid or tricuspid aortic
valves, we held the comparative study in subgroups of
patients who originally had tricuspid, bicuspid, or unicuspid
aortic valves. Furthermore, the transition of averaged
peak pressure gradient through the aortic valves showed
no significant differences in the 3 subgroups (Figure 4).DISCUSSION
The choice of strategy among variable aortic valve
surgical procedures is still controversial, especially for
younger patients. The available surgical treatments of aortic
valve disease are repair and replacement of the aortic valve.
Valve-sparing operations can be categorized broadly into
interventions on the aortic valve itself and those aimed at
repairing the proximal aorta.
Aortic valve reconstruction is now acknowledged as a
safe and effective operation for aortic valve disease. The
recent large-scale study of aortic valve reconstruction
with 7883 Japanese patients from 2005 to 2008 showed
an operative mortality of 3%.8 Conventional aortic valve
reconstruction presents complications resulting from
prosthetic valves. Mechanical valves require lifelong anti-
coagulation, and bioprosthesis is associated with high
rates of structural valvular degeneration.9,10 The stented
bioprosthesis showed progressive calcification at the base
of each cusp, notably near the commissure.11 Even with a
stentless prosthesis, calcification may be present along
the aortic wall.11 During the follow-up of all 108 patients
aged less than 60 years in the current series, we found no
signs of calcification. The following case is a good
example. We performed our original aortic valve recon-
struction on a 14-year-old boy with a failed unicuspid aortic
valve (Figure 5, A). Echocardiographic follow-up 3.5 yearsrdiovascular Surgery c Volume 148, Number 3 935
FIGURE 2. Mechanism and effect of the encircling felt strip at the commissural level.
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motion of the 3 cusps (Figure 5, B). Moreover, patients
aged less than 40 years showed excellent hemodynamics
after surgery, including this 14-year-old boy (Figure 5, C).
TheRoss procedurewas developed in an attempt toprovide
a permanent biological aortic valve prosthesis using the autol-
ogous pulmonic valve. This operation is especially effective
for pediatric patients. It provides excellent hemodynamics
but requires expertise and has several disadvantages, among
which are failure of the pulmonary homograft and dilatation
of native aortic root or pulmonary autograft.12,13 In the
current study, because of the felt strip encircling the aorta at
the commissural level and the running suture of the 3 cusps,
we observed no postoperative annular dilation even in theFIGURE 3. A, Survival curve after aortic valve reconstruction of 108
patients aged less than 60 years. B, Freedom from reoperation curve after
aortic valve reconstruction of 108 patients aged less than 60 years.
936 The Journal of Thoracic and Cardiovascular Surg14-year-old boy.Both of these procedures prevent the dilation
of the aorta and aortic annulus, which in turn prevents future
aortic regurgitation (Figure 5, D).
Various aortic valve repair techniques have been reported
showing good results.14-19 Successful bicuspidization repair
also has been reported.19 On the contrary, with the congen-
ital bicuspid aortic valve, AS might occur at a mean age less
than 60 years, and aortic regurgitation might develop at a
mean age less than 30 years.20,21 Although the exact
mechanism of proximal aortic dilatation has not been
clarified, a report shows that the significantly higher shear
forces might have an impact on the development of aortic
dilatation in patients with bicuspid aortic valves.22 Original
aortic valve reconstruction is exclusively tricuspidization,
which is basically a tricuspid replacement using autologous
pericardium. We believe tricuspidization is the ideal
reconstructive technique rather than bicuspidization. The
orientation of the cusps in a tricuspid valve allows each
cusp to fully open while maintaining the circular shape of
the aortic valve, which is why we perform our originalFIGURE 4. Transition of averaged peak pressure gradient through the
aortic valve from preoperative data to postoperative follow-up: Compara-
tive study among 3 patients’ subgroups of preoperative tricuspid, bicuspid,
and unicuspid aortic valves. BAV, Bicuspid aortic valve; LV-Ao, left
ventricular-aortic; TAV, tricuspid aortic valve; UAV, unicuspid aortic valve.
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FIGURE 5. A, Operative view of pre- (a) and post- (b) tricuspidized repair of unicuspid aortic valve in a 14-year-old boy. B, Preoperative echocardiography
of unicuspid aortic valve in a 14-year-old boy (a) and diastolic and systolic phases of tricuspidized valve 3.5 years after operation (b, c). C, Average peak
pressure gradient through the aortic valve in patients aged less than 40 years (red line indicates transition of peak pressure gradient in a 14-year-old boy with
congenital unicuspid valve). D, Average aortic valve annular diameter in patients aged less than 40 years (red line indicates transition of aortic valve annular
diameter in a 14-year-old boy with congenital unicuspid valve). LV-Ao, Left ventricular-aortic.
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Daortic valve reconstruction for tricuspidization. In this
study, we observed the compatible hemodynamics of
tricuspidized bicuspid or unicuspid aortic valves with
tricuspid valve cases (Figure 4). Tricuspidization is impor-
tant for full opening of the cusps.
This procedure preserves the coordination of the left
ventricle, aortic valve annulus, aortic valve cusps, sinus of Val-
salva, and sinotubular junction to maximize aortic valve func-
tion.Natural annularmotion can be preservedwith our original
aortic valve reconstruction and contributes to the postoperative
low pressure gradient through the pericardial aortic valve.Study Limitations
A limitation of the current study is the lack of long-term
follow-up. We will continue to monitor the results for a
longer follow-up period with a larger number of patients.The Journal of Thoracic and CaCONCLUSIONS
Our original aortic valve reconstruction with
glutaraldehyde-treated autologous pericardium has shown
good short- and midterm results for patients aged less
than 60 years. Our results show that tricuspidization not
only preserves the natural motion of the aortic valve but
also maintains a low pressure gradient and minimal regurgi-
tation. Long-term data will be disclosed in the future.References
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